This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Monitoring Arrhythmia Patients (IMPACT)

This study has been completed.
Information provided by:
Corventis, Inc. Identifier:
First received: June 10, 2009
Last updated: February 2, 2010
Last verified: February 2010
Prospective, multicenter, non-randomized study to determine the performance of NUVANT Mobile Cardiac Telemetry system in arrhythmia detection.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Arrhythmia Detection With Adherent Patient Monitoring

Further study details as provided by Corventis, Inc.:

Enrollment: 28
Study Start Date: June 2009
Study Completion Date: November 2009
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Detailed Description:
Arrhythmia patients will be externally monitored. The collected information will be used to evaluate the NUVANT MCT system.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Remote cardiac monitoring

Inclusion Criteria:

  • 18 years of age or older
  • Patients undergoing remote ambulatory electrocardiographic monitoring

Exclusion Criteria:

  • Is participating in another clinical study that may confound the results of this study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00919568

United States, Ohio
Dr. Bedi
Steubenville, Ohio, United States, 43952
Sponsors and Collaborators
Corventis, Inc.
Study Director: Imad Libbus, PhD Corventis, Inc.
  More Information

Responsible Party: Madhuri Bhat, VP Clinical and Regulatory affairs, Corventis Identifier: NCT00919568     History of Changes
Other Study ID Numbers: COR-2009-005
Study First Received: June 10, 2009
Last Updated: February 2, 2010 processed this record on September 21, 2017